Cargando…

Ultra-Large-Scale Screening of Natural Compounds and Free Energy Calculations Revealed Potential Inhibitors for the Receptor-Binding Domain (RBD) of SARS-CoV-2

The emergence of immune-evading variants of SARS-CoV-2 further aggravated the ongoing pandemic. Despite the deployments of various vaccines, the acquired mutations are capable of escaping both natural and vaccine-induced immune responses. Therefore, further investigation is needed to design a decisi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lisha, Zafar, Faryar, Moeen, Nawal, Alshabrmi, Fahad M., Lin, Junqi, Ali, Syed Shujait, Munir, Muhammad, Khan, Abbas, Wei, Dongqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656483/ https://www.ncbi.nlm.nih.gov/pubmed/36364143 http://dx.doi.org/10.3390/molecules27217317

Ejemplares similares

Blocking key mutated hotspot residues in the RBD of the omicron variant (B.1.1.529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches
por: Khan, Abbas, et al.
Publicado: (2022)

Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations
por: Khan, Abbas, et al.
Publicado: (2023)

Free Energy Perturbation Calculations of Mutation Effects on SARS-CoV-2 RBD::ACE2 Binding Affinity
por: Sergeeva, Alina P., et al.
Publicado: (2023)

Towards an Ensemble Vaccine against the Pegivirus Using Computational Modelling Approaches and Its Validation through In Silico Cloning and Immune Simulation
por: Zheng, Bowen, et al.
Publicado: (2021)

Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
por: Omotuyi, Olaposi, et al.
Publicado: (2023)

Structural-Dynamics and Binding Analysis of RBD from SARS-CoV-2 Variants of Concern (VOCs) and GRP78 Receptor Revealed Basis for Higher Infectivity
por: Khan, Abbas, et al.
Publicado: (2021)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Tag-Free SARS-CoV-2 Receptor Binding Domain (RBD), but Not C-Terminal Tagged SARS-CoV-2 RBD, Induces a Rapid and Potent Neutralizing Antibody Response
por: Lin, Ting-Wei, et al.
Publicado: (2022)

In Silico Mutagenesis-Based Remodelling of SARS-CoV-1 Peptide (ATLQAIAS) to Inhibit SARS-CoV-2: Structural-Dynamics and Free Energy Calculations
por: Khan, Abbas, et al.
Publicado: (2021)

Structural and Dynamic Insights into the W68L, L85P, and T87A Mutations of Mycobacterium tuberculosis Inducing Resistance to Pyrazinamide
por: Alatawi, Eid A., et al.
Publicado: (2022)

Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
por: Khan, Abbas, et al.
Publicado: (2020)

Structurally unique interaction of RBD-like and PH domains is crucial for yeast pheromone signaling
por: Yerko, Volodymyr, et al.
Publicado: (2013)

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD
por: Ma, Hang, et al.
Publicado: (2022)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Accommodating receptor flexibility and free energy calculation to reduce false positive binders in the discovery of natural products blockers of SARS-COV-2 spike RBD-ACE2 interface
por: Ogedjo, Marcelina, et al.
Publicado: (2021)

Label free detection of SARS CoV-2 Receptor Binding Domain (RBD) protein by fabrication of gold nanorods deposited on electrochemical immunosensor (GDEI)
por: Shahdeo, Deepshikha, et al.
Publicado: (2022)

Structural and Functional Characterization of SARS-CoV-2 RBD Domains Produced in Mammalian Cells
por: Gstöttner, Christoph, et al.
Publicado: (2021)

Bacillus subtilis spores displaying RBD domain of SARS-CoV-2 spike protein
por: Vetráková, A., et al.
Publicado: (2023)

Impact of domain knowledge on blinded predictions of binding energies by alchemical free energy calculations
por: Mey, Antonia S. J. S., et al.
Publicado: (2017)

Absolute binding free energy calculations improve enrichment of actives in virtual compound screening
por: Feng, Mudong, et al.
Publicado: (2022)

Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates
por: Kim, Felix J, et al.
Publicado: (2006)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2020)

Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays
por: Mehalko, Jennifer, et al.
Publicado: (2021)

SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study)
por: Hajizadeh, Faezeh, et al.
Publicado: (2022)

Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
por: Kaewchim, Kanasap, et al.
Publicado: (2023)

Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants
por: Wu, Yan, et al.
Publicado: (2023)

Carer Empowerment Is Key to Reduce Dementia Care Inequalities in the Middle East
por: Javaid, Syed Fahad, et al.
Publicado: (2021)

Automation of absolute protein-ligand binding free energy calculations for docking refinement and compound evaluation
por: Heinzelmann, Germano, et al.
Publicado: (2021)

A computational perspective on the dynamic behaviour of recurrent drug resistance mutations in the pncA gene from Mycobacterium tuberculosis
por: Khan, Taimoor, et al.
Publicado: (2021)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

E484K mutation in SARS-CoV-2 RBD enhances binding affinity with hACE2 but reduces interactions with neutralizing antibodies and nanobodies: Binding free energy calculation studies
por: Wang, Wei Bu, et al.
Publicado: (2021)

Identification of Potential Binding Sites of Sialic Acids on the RBD Domain of SARS-CoV-2 Spike Protein
por: Li, Bingqian, et al.
Publicado: (2021)

Utilization of Recombinant Baculovirus Expression System to Produce the RBD Domain of SARS-CoV-2 Spike Protein
por: Fan, Youpeng, et al.
Publicado: (2022)

An integrated understanding of the evolutionary and structural features of the SARS-CoV-2 spike receptor binding domain (RBD)
por: Sanyal, Dwipanjan, et al.
Publicado: (2022)

Protein-protein conjugation enhances the immunogenicity of SARS-CoV-2 receptor-binding domain (RBD) vaccines
por: Scaria, Puthupparampil V., et al.
Publicado: (2022)

Human antibody recognition and neutralization mode on the NTD and RBD domains of SARS-CoV-2 spike protein
por: Otsubo, Ryota, et al.
Publicado: (2022)

Mutational analysis of the spike protein of SARS-COV-2 isolates revealed atomistic features responsible for higher binding and infectivity
por: Hanifa, Muhammad, et al.
Publicado: (2023)

Deep-learning-based target screening and similarity search for the predicted inhibitors of the pathways in Parkinson's disease
por: Khan, Abbas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mnsotd28ju04tkcpp6h8f3pks2